Ocular venous occlusion in pediatrics: Should thrombophilia investigation and anticoagulant treatment be initiated?
Marganit BenishShai ShrotAssaf BargIris KventselRonit ElhasidGili KenetSarina Levy-MendelovichPublished in: Pediatric blood & cancer (2023)
Retinal vein occlusion (RVO) and superior ophthalmic vein thrombosis (SOVT) are rare diseases in the pediatric population; however, the ophthalmic and neurologic morbidity are significant. As published data are scarce for these conditions, we present our experience with pediatric ocular venous thrombosis in four patients, and discuss recommended management for evaluation and treatment. We suggest performing thrombophilia workup for all pediatric patients with RVO or SOVT. In patients with thrombophilia risk factors or patients with additional thrombi, we highly recommend initiating anticoagulation therapy. There is a need for more research in order to determine the optimal management strategy.
Keyphrases
- risk factors
- end stage renal disease
- atrial fibrillation
- ejection fraction
- venous thromboembolism
- pulmonary embolism
- optical coherence tomography
- peritoneal dialysis
- systematic review
- stem cells
- bone marrow
- electronic health record
- machine learning
- mesenchymal stem cells
- diabetic retinopathy
- replacement therapy
- big data
- data analysis
- meta analyses